Browse > Article
http://dx.doi.org/10.3904/kjim.2010.25.3.317

Induction of Macrophage Migration Inhibitory Factor in ConA-Stimulated Rheumatoid Arthritis Synovial Fibroblasts through the P38 MAP Kinase-Dependent Signaling Pathway  

Kim, Hae-Rim (Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine)
Park, Mi-Kyung (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Cho, Mi-La (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Kim, Kyoung-Woon (Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine)
Oh, Hye-Joa (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Park, Jin-Sil (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Heo, Yang-Mi (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Lee, Sang-Heon (Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine)
Kim, Ho-Youn (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Park, Sung-Hwan (Rheumatism Research Center, Catholic Institute of Medical Sciences, The Catholic University of Korea)
Publication Information
The Korean journal of internal medicine / v.25, no.3, 2010 , pp. 317-326 More about this Journal
Abstract
Background/Aims: This study was undertaken to identify the intracellular signaling pathway involved in induction of macrophage migration inhibitory factor (MIF) in human rheumatoid arthritis (RA) synovial fibroblasts. Methods: Human RA synovial fibroblasts were treated with concanavalin A (ConA), various cytokines, and inhibitors of signal transduction molecules. The production of MIF by synovial fibroblasts was measured in culture supernatants by ELISA. The expression of MIF mRNA was determined using reverse transcriptase polymerase chain reaction (RT-PCR) and real-time PCR. Phosphorylation of p38 mitogen-activated protein (MAP) kinase in synovial fibroblasts was confirmed using Western blotting. The expression of MIF and p38 MAP kinase in RA synovium was determined using dual immunohistochemistry. Results: The production of MIF by RA synovial fibroblasts increased in a dose-dependent manner after ConA stimulation. MIF was also induced by interferon-${\gamma}$, CD40 ligand, interleukin-15, interleukin-$1{\beta}$, tumor necrosis factor-${\alpha}$, and transforming growth factor-${\beta}$. The production of MIF by RA synovial fibroblasts was significantly reduced after inhibition of p38 MAP kinase. The expression of MIF and p38 MAP kinase was upregulated in the RA synovium compared with the osteoarthritis synovium. Conclusions: These results suggest that MIF production was induced through a p38 MAP-kinase-dependent pathway in RA synovial fibroblasts.
Keywords
Macrophage; migration-inhibitory factors; Arthritis rheumatoid; Synovial fibroblast; p38 mitogen-activated protein kinases;
Citations & Related Records

Times Cited By SCOPUS : 2
연도 인용수 순위
1 Hudson JD, Shoaibi MA, Maestro R, et al. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999; 190:1375-1382.   DOI   ScienceOn
2 Onodera S, Tanji H, Suzuki K, et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999;11:163-167.   DOI   ScienceOn
3 Miyazawa K, Mori A, Miyata H, Akahane M, Ajisawa Y, Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogenactivated protein kinase. J Biol Chem 1998;273:24832-24838.   DOI   ScienceOn
4 Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002;99:345-350.   DOI   ScienceOn
5 Kumagi T, Akbar F, Horiike N, Onji M. Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin Biochem 2001;34:189-193.   DOI   ScienceOn
6 Schett G, Zwerina J, Firestein G. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 2008;67:909-916.
7 Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci U S A 1998;95:11383-11388.   DOI   ScienceOn
8 Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 1997;185:1455-1465.   DOI   ScienceOn
9 Brennan F, Beech J. Update on cytokines in rheumatoid arthritis. Curr Opin Rheumatol 2007;19:296-301.   DOI   ScienceOn
10 Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, Yoshikawa H. Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 2003;48:2670-2681.   DOI   ScienceOn
11 Aeberli D, Yang Y, Mansell A, Santos L, Leech M, Morand EF. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett 2006; 580:974-981.   DOI   ScienceOn
12 Pargellis C, Regan J. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Curr Opin Investig Drugs 2003;4:566-571.
13 Piecyk M, Anderson P. Signal transduction in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15:789-803.   DOI   ScienceOn
14 Suzuki M, Tetsuka T, Yoshida S, et al. The role of p38 mitogenactivated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett 2000;465:23-27.   DOI   ScienceOn
15 Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M, Lee JC. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol 2001;187:294-303.   DOI   ScienceOn
16 Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, Todo S. Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann N Y Acad Sci 2003;995:171-182.   DOI   ScienceOn
17 Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoidinduced modulator of cytokine production. Nature 1995;377:68-71.   DOI   ScienceOn
18 Leng L, Metz CN, Fang Y, et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003;197:1467-1476.   DOI   ScienceOn
19 Schett G, Tohidast-Akrad M, Smolen JS, et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000;43:2501- 2512.   DOI   ScienceOn
20 Lan HY, Yang N, Metz C, et al. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 1997;3:136-144.
21 Leech M, Metz C, Santos L, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998;41:910-917.   DOI   ScienceOn
22 Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999;5:181-191.
23 Ogawa H, Nishihira J, Sato Y, et al. An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 2000;12:309-314.   DOI   ScienceOn
24 Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158: 5514-17.
25 Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-82.   DOI   ScienceOn
26 Bernhagen J, Bacher M, Calandra T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayedtype hypersensitivity reaction. J Exp Med 1996;183:277-282.   DOI   ScienceOn
27 Lan HY, Mu W, Yang N, et al. De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996;149:1119-1127.
28 Santos LL, Lacey D, Yang Y, Leech M, Morand EF. Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. J Rheumatol 2004;31:1038-1043.
29 David JR. Delayed hypersensitivity in vitro: its mediation by cellfree substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 1966;56:72-77.   DOI   ScienceOn
30 Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitaryderived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-759.   DOI   ScienceOn
31 Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002;4:449-460.   DOI   ScienceOn
32 Onodera S, Nishihira J, Iwabuchi K, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002;277:7865-7874.   DOI   ScienceOn
33 Leech M, Lacey D, Xue JR, et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 2003;48:1881-1889.   DOI   ScienceOn
34 Kim HR, Park MK, Cho ML, et al. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol 2007;34:927-936.
35 Overall CM, Sodek J. Concanavalin A produces a matrixdegradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J Biol Chem 1990;265:21141-21151.
36 Metz C, Bucala R, Smith MD. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002;41:558-562.   DOI   ScienceOn
37 Lacey D, Sampey A, Mitchell R, et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 2003;48:103-109.   DOI   ScienceOn
38 Kleemann R, Hausser A, Geiger G, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000;408:211-216.   DOI   ScienceOn
39 Leech M, Metz C, Hall P, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999;42:1601-1608.   DOI   ScienceOn
40 Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 2003;48:291-299.   DOI   ScienceOn
41 Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogenactivated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999;274:18100-18106.   DOI
42 Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-450.   DOI   ScienceOn
43 Hurum S, Sodek J, Aubin JE. Synthesis of collagen, collagenase and collagenase inhibitors by cloned human gingival fibroblasts and the effect of concanavalin A. Biochem Biophys Res Commun 1982;107:357-366.   DOI   ScienceOn
44 Scheinecker C, Redlich K, Smolen JS. Cytokines as therapeutic targets: advances and limitations. Immunity 2008;28:440-444.   DOI   ScienceOn
45 Gunther GR, Wang JL, Yahara I, Cunningham BA, Edelman GM. Concanavalin A derivatives with altered biological activities. Proc Natl Acad Sci U S A 1973;70:1012-1016.   DOI   ScienceOn
46 Feng GS. Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation. Cell Res 2007;17:37-41.   DOI   ScienceOn